8-K - REGENXBIO Inc. | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

. Other Events. On January 28, 2026, REGENXBIO Inc. (the “Company”) announced that it received communication from the U.S. Food and Drug Administration (“FDA”)

Other Event

9.01

. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release dated January 28, 2026. 104 The cover page from this Current Report

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1